Lifeward’s First Annual Step Challenge Donates €5,000 to German Association for People Living with Spinal Cord Injury
Lifeward (Nasdaq: LFWD) has successfully completed its first ReWalk Step Challenge 2024, a charity initiative involving ReWalk Personal Exoskeleton users in Germany. The challenge resulted in a €5,000 donation to the Association for the Promotion of Paraplegics in Germany (FGQ). Participants collectively achieved 424,844 steps during the one-month challenge, with Lifeward donating one cent per step taken.
The funds will support FGQ's mission to assist people with spinal cord injuries and their families. Lifeward CEO Larry Jasinski expressed satisfaction with the community's engagement and the opportunity to support the European Spinal Cord Injury Federation (ESCIF). The company plans to repeat the challenge next year, aiming for increased participation to further support the paraplegic community.
Lifeward (Nasdaq: LFWD) ha completato con successo la sua prima ReWalk Step Challenge 2024, un'iniziativa di beneficenza che coinvolge gli utenti del ReWalk Personal Exoskeleton in Germania. La sfida ha portato a una donazione di €5.000 all'Associazione per la Promozione dei Paraplegici in Germania (FGQ). I partecipanti hanno collettivamente raggiunto 424.844 passi durante la sfida di un mese, con Lifeward che ha donato un centesimo per ogni passo effettuato.
I fondi supporteranno la missione della FGQ di assistere persone con lesioni spinali e le loro famiglie. Il CEO di Lifeward, Larry Jasinski, ha espresso soddisfazione per il coinvolgimento della comunità e per l'opportunità di supportare la Federazione Europea delle Lesioni Spinali (ESCIF). L'azienda prevede di ripetere la sfida il prossimo anno, puntando a un aumento della partecipazione per sostenere ulteriormente la comunità dei paraplegici.
Lifeward (Nasdaq: LFWD) ha completado con éxito su primer ReWalk Step Challenge 2024, una iniciativa benéfica que involucra a los usuarios del exoesqueleto ReWalk en Alemania. El desafío resultó en una donación de €5,000 a la Asociación para la Promoción de Parapléjicos en Alemania (FGQ). Los participantes lograron colectivamente 424,844 pasos durante el desafío de un mes, con Lifeward donando un céntimo por cada paso dado.
Los fondos apoyarán la misión de la FGQ de asistir a personas con lesiones de médula espinal y sus familias. El CEO de Lifeward, Larry Jasinski, expresó satisfacción con el compromiso de la comunidad y la oportunidad de apoyar a la Federación Europea de Lesiones de Médula Espinal (ESCIF). La empresa planea repetir el desafío el próximo año, con el objetivo de aumentar la participación para apoyar aún más a la comunidad parapléjica.
Lifeward (Nasdaq: LFWD)는 독일의 ReWalk 개인 외골격 사용자들이 참여하는 자선 이니셔티브인 첫 번째 ReWalk Step Challenge 2024를 성공적으로 마쳤습니다. 이 도전은 독일의 paraplegics 촉진 협회(FGQ)에 5,000 유로의 기부로 이어졌습니다. 참가자들은 한 달 동안 총 424,844 보를 달성했으며, Lifeward는 걸음마다 1유로 센트를 기부했습니다.
모금된 자금은 FGQ의 척수 손상 환자 및 그 가족을 돕기 위한 임무를 지원합니다. Lifeward의 CEO인 Larry Jasinski는 커뮤니티의 참여와 유럽 척수 손상 연맹(ESCIF)을 지원할 기회에 대한 만족감을 표시했습니다. 회사는 내년에 도전을 반복할 계획이며, paraplegic 커뮤니티를 보다 잘 지원하기 위해 참여를 늘리려 합니다.
Lifeward (Nasdaq: LFWD) a complété avec succès son premier ReWalk Step Challenge 2024, une initiative caritative impliquant les utilisateurs d'exosquelettes ReWalk en Allemagne. Le défi a abouti à une dons de 5 000 € à l'Association pour la Promotion des Paraplégiques en Allemagne (FGQ). Les participants ont collectivement atteint 424 844 pas durant le défi d'un mois, Lifeward faisant un don d'un centime par pas effectué.
Les fonds soutiendront la mission de la FGQ d'assister les personnes atteintes de lésions de la moelle épinière et leurs familles. Le PDG de Lifeward, Larry Jasinski, a exprimé sa satisfaction face à l'engagement de la communauté et à l'opportunité de soutenir la Fédération Européenne des Lésions de la Moelle Épinière (ESCIF). L'entreprise prévoit de répéter le défi l'année prochaine, visant à accroître la participation pour mieux soutenir la communauté des paraplégiques.
Lifeward (Nasdaq: LFWD) hat erfolgreich seine erste ReWalk Step Challenge 2024 abgeschlossen, eine Wohltätigkeitsinitiative, die Nutzer des ReWalk-Personenexoskeletts in Deutschland einbezieht. Die Herausforderung führte zu einer Spende von 5.000 € an die Vereinigung zur Förderung von Querschnittsgelähmten in Deutschland (FGQ). Die Teilnehmer erreichten während der einmonatigen Herausforderung gemeinsam 424.844 Schritte, wobei Lifeward einen Cent pro Schritt spendete.
Die Mittel unterstützen die Mission der FGQ, Menschen mit Rückenmarksverletzungen und deren Familien zu helfen. Der CEO von Lifeward, Larry Jasinski, äußerte Zufriedenheit über das Engagement der Gemeinschaft und die Möglichkeit, die Europäische Rückenmarkverletzungsföderation (ESCIF) zu unterstützen. Das Unternehmen plant, die Herausforderung im nächsten Jahr zu wiederholen, mit dem Ziel, die Teilnahme zu erhöhen, um die Querschnittsgelähmten-Gemeinschaft weiter zu unterstützen.
- Successful completion of the first ReWalk Step Challenge 2024
- €5,000 donation made to the Association for the Promotion of Paraplegics in Germany (FGQ)
- 424,844 steps achieved collectively by ReWalk Exoskeleton users in Germany
- Plans to repeat the challenge next year with aims for increased participation
- None.
As part of the fundraising “Step Challenge”, ReWalk users in Germany completed 424,844 steps to raise 5,000 Euros for the European Spinal Cord Injury Federation (“ESCIF”)
MARLBOROUGH, Mass., BERLIN, Germany, and YOKNEAM ILLIT, Israel, Sept. 05, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (DBA Lifeward™) (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life’s passions in the face of physical limitation or disability, is pleased to announce the successful completion of the first ReWalk Step Challenge 2024. This unique charity initiative brought together the community of ReWalk Personal Exoskeleton users in Germany with the aim of completing as many steps as possible in their ReWalk Exoskeleton while supporting a good cause.
During the Step Challenge, Lifeward committed to donating one cent to charity for each step that was taken by participating ReWalk users in Germany (“ReWalkers”) in their ReWalk Exoskeleton during the course of the one-month challenge. The German ReWalker community collectively achieved an impressive 424,844 steps during the charity initiative, which was rounded up to a total donation of 5,000 Euros. The funds were donated to the “Association for the Promotion of Paraplegics in Germany” (“FGQ”), which offers lifelong support and advice to people with spinal cord injuries and their relatives and raises awareness of the needs of people with spinal cord injuries at various levels.
“Lifeward, the FGQ and the European umbrella organization, the European Spinal Cord Injury Federation (“ESCIF”), share the common goal of improving the quality of life for people with spinal cord injuries,” said Larry Jasinski, CEO of Lifeward. “We are pleased to see how the ReWalker community has risen to this challenge to support Lifeward's donation to such an important organization. We look forward to further opportunities to collaborate with FGQ and ESCIF.”
Kevin Schultes, Chairman of the FGQ Board, was delighted with the great fundraising campaign and emphasized the importance of this support: “As a non-profit and charitable association, we rely on donations to secure and sustainably develop the FGQ's rapidly growing range of services.”
One of the participating ReWalkers, Linda Wagemann, also expressed her enthusiasm: “I like challenges. The ReWalk Step Challenge gave me incredible motivation to walk as much as possible and set an example for others. I was extremely excited to see how many steps I could take personally and how many steps we could take together as a ReWalk community in a month. Knowing that every step also benefits other people gave me extra motivation. I'm already looking forward to the next challenge!”
Lifeward GmbH will repeat the ReWalk Step Challenge next year and hopes that even more users of the ReWalk Personal Exoskeleton will participate in order to further strengthen and support the paraplegic community.
About Lifeward
Lifeward designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering proven functional and health benefits in clinical settings as well as in the home and community. Our mission at Lifeward is to relentlessly drive innovation to change the lives of individuals with physical limitations or disabilities. We are committed to delivering groundbreaking solutions that empower individuals to do what they love. The Lifeward portfolio features innovative products including the ReWalk Exoskeleton, the AlterG Anti-Gravity system, the MyoCycle FES System, and the ReStore Exo-Suit.
Founded in 2001, Lifeward has operations in the United States, Israel, and Germany. For more information on the Lifeward product portfolio, please visit GoLifeward.com.
ReWalk®, ReStore® and Alter G® are registered trademarks of ReWalk Robotics Ltd. (DBA Lifeward) and/or its affiliates.
Forward-Looking Statements
In addition to historical information, this press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. Such forward-looking statements may include projections regarding the Company’s future performance and other statements that are not statements of historical fact and, in some cases, may be identified by words like "anticipate," "assume," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "future," "will," "should," "would," "seek," and similar terms or phrases. The forward-looking statements contained in this press release are based on management's current expectations, which are subject to uncertainty, risks and changes in circumstances that are difficult to predict and many of which are outside of Lifeward’s control. Important factors that could cause the Company’s actual results to differ materially from those indicated in the forward-looking statements are more fully discussed in the Company’s periodic filings with the Securities and Exchange Commission (“SEC”), including the risk factors described under the heading "Risk Factors" in the Company’s annual report on Form 10-K and 10-K/A, as amended, for the year ended December 31, 2023 filed with the SEC and other documents subsequently filed with or furnished to the SEC. Any forward-looking statement made in this press release speaks only as of the date hereof. Factors or events that could cause the Company’s actual results to differ from the statements contained herein may emerge from time to time, and it is not possible for the Company to predict all of them. Except as required by law, Lifeward undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.
Lifeward Media Relations:
Kathleen O’Donnell
VP Marketing & New Business Development
Lifeward
E: media@golifeward.com
Lifeward Investor Contact:
Mike Lawless
Chief Financial Officer
Lifeward
E: ir@golifeward.com
FAQ
What was the outcome of Lifeward's (LFWD) first ReWalk Step Challenge 2024?
How much did Lifeward (LFWD) donate per step in the ReWalk Step Challenge 2024?
Will Lifeward (LFWD) repeat the ReWalk Step Challenge in the future?
Who benefited from the donation raised by Lifeward's (LFWD) ReWalk Step Challenge 2024?
